Abstracts from the Food Allergy and Anaphylaxis Meeting 2016

Guillaume Pouessel,Claire Claverie,Julien Labreuche,Jean-Marie Renaudin,Aimée Dorkenoo,Mireille Eb,Anne Moneret-Vautrin,Antoine Deschildre,Stephane Leteurtre,Linus Grabenhenrich,Margitta Worm,Sabine Dölle,Kathrin Scherer,Isidor Hutteger,Morten Christensen,Carsten Bindslev-Jensen,Charlotte Mortz,Esben Eller,Henrik Fomsgaard Kjaer,Leonor Carneiro-Leão,Jenny Badas,Alice Coimbra,Dikla Pivko Levy,Moshe Ben-Shoshan,Ayelet Rimon,Shira Benor,Nicolette J. T. Arends,Nikki Edelbroek,Hans de Groot,Joyce A. M. Emons,H. Kim A. Brand,Dirk Verhoeven,Leonieke N. van Veen,Nicolette W. de Jong,Geunwoong Noh,Eun Ha Jang,Mariona Pascal,Olga Dominguez,Mònica Piquer,Montserrat Alvaro,Rosa Jimenez-Feijoo,Jaime Lozano,Adriana Machinena,Maria del Mar Folqué,Maria Teresa Giner,Ana María Plaza,Paul Turner,Nandinee Patel,Marta Vazquez-Ortiz,Sarah Lindsley,Lucy Walker,Simon Rosenberg,Adriano Mari,Claudia Alessandri,Ivana Giangrieco,Lisa Tuppo,Chiara Rafaiani,Georg Mitterer,Michela Ciancamerla,Rosetta Ferrara,Maria Livia Bernardi,Danila Zennaro,Maurizio Tamburrini,Maria Antonetta Ciardiello,Christian Harwanegg,Antonio Fernandez,Regina Selb,Philippe Egenmann,Michelle Epstein,Karin Hoffmann-Sommergruber,Frits Koning,Martinus Lovik,E. N. Clare Mills,Javier Moreno,Henk van Loveren,Jean-Michel Wal,Susanne Diesner,Cornelia Bergmayr,Barbara Pfitzner,Vera Elisabeth Assmann,Philipp Starkl,David Endesfelder,Thomas Eiwegger,Zsolt Szepfalusi,Heinz Fehrenbach,Erika Jensen-Jarolim,Anton Hartmann,Isabella Pali-Schöll,Eva Untersmayr,Soren Wille,Peter Meyer,Caroline Klingebiel,Jonas Lidholm,Angelica Ehrenberg,Jonas Östling,Isabelle Cleach,Jean-Louis Mège,Joana Vitte,Roberta Aina,Pawel Dubiela,Sabine Pfeifer,Merima Bublin,Christian Radauer,Piotr Humeniuk,Stefan Kabasser,Riccardo Asero,Gador Bogas,Francisca Gomez,Paloma Campo,Maria Salas,Inmaculada Doña,Esther Barrionuevo,Maria Auxiliadora Guerrero,Cristobalina Mayorga,Ana Prieto,Domingo Barber,Maria Jose Torres,Annette Jamin,Andrea Wangorsch,Barbara Ballmer,Stefan Vieths,Stephan Scheurer,Danijela Apostolovic,Jelena Mihailovic,Maja Krstic,Maria Starkhammar,Tanja Cirkovic Velickovic,Carl Hamsten,Marianne van Hage,Francine C. van Erp,Edward F. Knol,Hannah M. Kansen,Bo Pontoppidan,Yolanda Meijer,Cornelis K. van der Ent,André C. Knulst,Rebekah Sayers,Helen Brown,Adnan Custovic,Angela Simpson,Claire Mills,Juliane Schulz,Network for Online Registration of Anaphylaxis (NORA),Jaap Akkerdaas,Muriel Totis,Annabelle Capt,Corinne Herouet-Guicheney,Ronald van Ree,Tushar Banerjee,Antima Banerjee,Mathilde Claude,Grégory Bouchaud,Roberta Lupi,Laure Castan,Olivier Tranquet,Sandra Denery-Papini,Marie Bodinier,Chantal Brossard,Rosella De Poi,Elisa Gritti,Emiliano De Dominicis,Bert Popping,Patrizia Polverino de Laureto,Kati Palosuo,Anna Kaarina Kukkonen,Anna Pelkonen,Mika Mäkelä,Nanju Alice Lee,Johanna Rost,Sridevi Muralidharan,Dianne Campbell,Sam Mehr,Catherine Nock,Joseph Baumert,Steve Taylor,Carla Mastrorilli,Salvatore Tripodi,Carlo Caffarelli,Serena Perna,Andrea Di Rienzo Businco,Ifigenia Sfika,Arianna Dondi,Annamaria Bianchi,Carlotta Povesi Dascola,Giampaolo Ricci,Francesca Cipriani,Nunzia Maiello,Michele Miraglia del Giudice,Tullio Frediani,Simone Frediani,Francesco Macrì,Chiara Pistoletti,Iride Dello Iacono,Maria Francesca Patria,Elena Varin,Diego Peroni,Pasquale Comberiati,Loredana Chini,Viviana Moschese,Sandra Lucarelli,Roberto Bernardini,Giuseppe Pingitore,Umberto Pelosi,Roberta Olcese,Matteo Moretti,Anastasia Cirisano,Diego Faggian,Alessandro Travaglini,Mario Plebani,Maria Carmen Verga,Mauro Calvani,Paolo Giordani,Paolo Maria Matricardi,Noe Ontiveros,Francisco Cabrera-Chavez,Julie Galand,Etienne Beaudouin,Florence Pineau,Shinobu Sakai,Kayoko Matsunaga,Reiko Teshima,Colette Larré,Sandra Denery,Sebastian Tschirner,Valérie Trendelenburg,Gabriele Schulz,Bodo Niggemann,Kirsten Beyer,Youcef Bouferkas,Younes Belabbas,Djamel Saidi,Omar Kheroua,Kamel Eddine El Mecherfi,Malika Guendouz,Abir Haddi,Hanane Kaddouri,Luis Amaral,Ana Pereira,Susana Rodrigues,Mareen Datema,Laurian Jongejan,Michael Clausen,Andre Knulst,Nikolaos Papadopoulos,Marek Kowalski,Frédéric de Blay,Aeilko Zwinderman,Karin Hoffman-Sommergruber,Barbara Ballmer-Weber,Montserrat Fernandez-Rivas,Shan Deng,Jia Yin,Charlotte Eisenmann,Maria Nassiri,Rabea Reinert,Johanna P. M. van der Valk,Roy Gerth van Wijk,Yvonne Vergouwe,Ewout W. Steyerberg,Marit Reitsma,Harry J. Wichers,Huub F. J. Savelkoul,Berber Vlieg-Boerstra,Anthony E. J. Dubois,Fabrícia Carolino,Ana Rodolfo,Josefina Cernadas,Dasha Roa-Medellín,Ana Rodriguez-Fernandez,Joaquín Navarro,Vicente Albendiz,María Luisa Baeza,Sonsoles Intente-Herrero,Andrea Mikkelsen,Kirsten Mehlig,Lauren Lissner,Linda Verrill,Stefano Luccioli,Jolanda van Bilsen,Frieke Kuper,André Wolterbeek,Tanja Rouhani Rankouhi,Lars Verschuren,Hilde Cnossen,Prescilla Jeurink,Johan Garssen,Léon Knippels,Jossie Garthoff,Geert Houben,Winfried Leeman,M. Eleonore Pettersson,Afke M. M. Schins,Gerard H. Koppelman,Boudewjin J. Kollen,Svitlana Zubchenko,Sarah Kuntz,Pablo Mérida,Montserrat Álvaro,Monica Piquer,Carmen Riggioni,Juan Heber Castellanos,Rosa Jimenez,Melanie Cap,Elodie Drumez,Stéphanie Lejeune,Caroline Thumerelle,Clémence Mordacq,Véronique Nève,Sonia Ricò,Margherita Varini,Rita Nocerino,Linda Cosenza,Antonio Amoroso,Margherita Di Costanzo,Carmen Di Scala,Giorgio Bedogni,Roberto Berni Canani,Paul J. Turner,Paloma Poza-Guedes,Ruperto González-Pérez,Inmaculada Sánchez-Machín,Victor Matheu-Delgado,Erik Wambre,Anne-Sofie Ballegaard,Charlotte Madsen,Juliane Gregersen,Katrine Lindholm Bøgh,Philippe Aubert,Michel Neunlist,Antoine Magnan,Daniel Lozano-Ojalvo,Alba Pablos-Tanarro,Leticia Pérez-Rodríguez,Elena Molina,Rosina López-Fandiño,Akila Rekima,Patricia Macchiaverni,Mathilde Turfkruyer,Sebastien Holvoet,Lénaïck Dupuis,Nour Baiz,Isabella Annesi-Maesano,Annick Mercenier,Sophie Nutten,Valérie Verhasselt,Ines Mrakovcic-Sutic,Srdan Banac,Ivana Sutic,Zdenka Baricev-Novakovic,Ingrid Sutic,Valentino Pavisic,Rosa Muñoz-Cano,Teodoríkez Jiménez-Rodríguez,Daniel Corbacho,Jordi Roca-Ferrer,Joan Bartra,Aleksandar Bulog,Vladimir Micovic,Lidia Markiewicz,Agata Szymkiewicz,Anna Szyc,Barbara Wróblewska,Bryan M. Harvey,Lucien F. Harthoorn,A. Wesley Burks,Georgios Rentzos,Anna-Lena Bramstång Björk,Ulf Bengtsson,Colin Barber,Chrystyna Kalicinsky,Christine Breynaert,Lieve Coorevits,Cornelia Jansen,Erna Van Hoeyveld,Kristin Verbeke,Anne-Marie Kochuyt,Rik Schrijvers,Diana Deleanu,Adriana Muntean,Maria Konstantakopoulou,Maria Pasioti,Anastasia Papadopoulou,Anna Iliopoulou,Nikolaos Mikos,Evangelia Kompoti,Eunice Dias de Castro,Borja Bartalomé,Kok Loong Ue,Elizabeth Griffiths,Stephen Till,Kate Grimshaw,Graham Roberts,Anna Selby,Indre Butiene,Jose Ignacio Larco,Ruta Dubakiene,Ana Fiandor,Alessandro Fiocchi,Nikos Papadopoulos,Sigurveig Sigurdardottir,Aline Sprikkelman,Anne-Fleur Schoemaker,Paraskevi Xepapadaki,Thomas Keil,Zizi Cojocariu,Beatriz Secades Barbado,Vasti Iancu,Esozia Arroabarren,Marta Goñi Esarte,Miren Arteaga,Mayra Coutinho Andrade,Denise Borges,Jorge Kalil,Pedro Giavina Bianchi,Rosana Camara Agondi,Rinkesh Kumar Gupta,Akanksha Sharma,Kriti Gupta,Mukul Das,Premendra Dwivedi,Rusudan Karseladze,Liana Jorjoliani,Lali Saginadze,Mariam Tskhakaia,Katia Basello,Gabriele Piuri,Attilio Francesco Speciani,Michela Carola Speciani,Carla Camerotto,Francesco Zinno,Olga Pakholchuk,Svitlana Nedelska,Stefano Pattini,Maria Teresa Costantino,Silvia Peveri,Danilo Villalta,Eleonora Savi,Andrea Costanzi,Vera A. Revyakina,Marina A. Kiseleva,Elena D. Kuvshinova,Inna A. Larkova,Anton A. Shekhetov,Diana Silva,André Moreira,José Plácido,Hanneke van der Kleij,Esther van Twuijver,Robbert Sutorius,Pieter-Jan de Kam,Jenny van Odijk,Helen Lindqvist,Elin Lustig,Amyra Ali Azamar Jácome,Karla Leversia Borjas Aguilar,Miguel García Domínguez,David Alejandro Mendoza Hernández,Cristiano Caruso,Cono Casale,Gian Lodovico Rapaccini,Antonino Romano,Italo De Vitis,Renata R. Cocco,Carolina Aranda,Marcia C. Mallozi,Jackeline F. Motta,Lilian Moraes,Antonio Pastorino,Nelson Rosario,Ekaterini Goudouris,Arnaldo Porto,Neusa F. Wandalsen,Emanuel Sarinho,Flavio Sano,Dirceu Solé,Constantinos Pitsios,Maria Petrodimopoulou,Ekaterini Papadopoulou,Maria Passioti,Meropi Kontogianni,Nino Adamia,Ekaterina Khaleva,Ana Prieto del Prado,George Du Toit,Edyta Krzych,Urszula Samolinska-Zawisza,Konrad Furmanczyk,Aneta Tomaszewska,Filip Raciborski,Agnieszka Lipiec,Piotr Samel-Kowalik,Artur Walkiewicz,Jacek Borowicz,Boleslaw Samolinski,Aimee Lou Nano,Marysia Recto,Maria Luisa Somoza,Natalia Blanca López,Diana Pérez Alzate,Francisco Javier Ruano,Maria Isabel Garcimartín,Elisa Haroun,Maria Vázquez de la Torre,Antonia Rojas,Montserrat López Onieva,Gabriela Canto,Alexandra Rodrigues,Andreia Forno,António Jorge Cabral,Rute Gonçalves,Ilya Vorozhko,Tatyana Sentsova,Olga Chernyak,Svetlana Denisova,Lidia Ilènko,Valery Muhortnich,Caroline Zimmermann,Alexander Rohrbach,Faisal R. Bakhsh,Kollen Boudewijn,Anne-Marie Oomkes-Pilon,Dorien Van Ginkle,Mira Šilar,Anja Jeverica,Tina Vesel,Tadej Avčin,Peter Korošec,Johanna van der Valk,Irene Berends,Nicolette Arends,Maurits van Maaren,Harry Wichers,Joyce Emons,Anthony Dubois,Nicolette de Jong,Oksana Matsyura,Lesya Besh,Chung-Hsiung Huang,Tong-Rong Jan,Gary Stiefel,Jean Tratt,Kerrie Kirk,Fabricia Carolino,Stefania Arasi,Lucia Caminiti,Giuseppe Crisafulli,Chiara Fiamingo,Jlenia Fresta,Giovanni Pajno,Ben Remington,Astrid Kruizinga,W. Marty Blom,Joost Westerhout,Sabina Bijlsma,Joe Baumert,Mark Blankestijn,Henny Otten,Rob Klemans,Anouska D. Michelsen-Huisman,Harmieke van Os-Medendorp,Astrid G. Kruizinga,Astrid Versluis,Gert van Duijn,H. Mary-Lene de Zeeuw-Brouwer,Jacqueline J. M. Castenmiller,Hub P. J. M. Noteborn,Geert F. Houben,Kristian Bravin,David Luyt,Bushra Javed,Phil Couch,Christopher Munro,Phil Padfield,Matt Sperrin,Aideen Byrne,Lizalet Oosthuizen,Carina Kelleher,Fiona Ward,Niamh Brosnan,Graham King,Eva Corbet,Josué Alejandro Huertas Guzmán,Montserrat Bosque García,Oscar Asensio,Laura Valdesoiro Navarrete,Helena Larramona,Xavier Domingo Miró,Katarzyna Pyrz,Moira Austin,Yanne Boloh,Philip Couch,Deirdre Galloway,Pilar Hernandez,Jonathan O’B. Hourihane,Fiona Kenna,Barbara Majkowska-Wojciechowska,Lynne Regent,Marina Themisb,Sabine Schnadt,Aida Semic-Jusufagic,Audrey Dunn Galvin,Tiina Kauppila,Mikael Kuitunen,Nikolaos A. Kitsioulis,Nikolaos Douladiris,Sofia Kostoudi,Ioanna Manolaraki,Dimitris Mitsias,Emmanouil Manousakis,Nikolaos G. Papadopoulos,Rebecca Knibb,Jennifer Hammond,Richard Cooke,Jaakko Yrjänä,Anna-Maija Hanni,Päivi Vähäsarja,Oona Mustonen,Teija Dunder,Petri Kulmala,Eva Lasa,Carmen D’Amelio,Sara Martínez,Alejandro Joral,Gabriel Gastaminza,Maria Jose Goikoetxea,David C. A. Candy,Marleen T. J. Van Ampting,Manon M. Oude Nijhuis,Assad M. Butt,Diego G. Peroni,Adam T. Fox,Jan Knol,Louise J. Michaelis,Ines Padua,Patricia Padrao,Pedro Moreira,Renata Barros,Hanan Sharif,Manzoor Ahmed,Nehad Gomaa,Joris Mens,Koen Smit,Frans Timmermans,Tomaž Poredoš,Anja Koren Jeverica,Marjeta Sedmak,Evgen Benedik,Meta Accetto,Mirjana Zupančič,Glauce Yonamine,Gustavo Soldateli,Bruna Aquilante,Antonio Carlos Pastorino,Cleonir Lui de Moraes Beck,Andrea Keiko Gushken,Mayra de Barros Dorna,Cristiane Nunes dos Santos,Ana Paula Moschione Castro,Abdulhadi Al-Qahtani,Rand Arnaout,Agha Rehan Khaliq,Rashid Amin,Farrukh Sheikh,Jorge Alvarez,Marta Anda,Miriam Palacios,Montserrat De Prada,Carmen Ponce,Bianca Balbino,Riccardo Sibilano,Thomas Marichal,Nicolas Gaudenzio,Hajime Karasuyama,Pierre Bruhns,Mindy Tsai,Laurent L. Reber,Stephen J. Galli,Ana Reis Ferreira,Josefina R. Cernadas,Aida del Campo García,Sara Pereiro Fernández,Nerea Sarmiento Carrera,Fernando Bandrés Sánchez-Cruz,José Ramón Fernández Lorenzo,Stephanie Claus,Claudia Pföhler,Franziska Ruëff,Regina Treudler,Mercedes Escarrer Jaume,Agustin Madroñero,Maria Teresa Guerra Perez,Juan Carlos Julia,Charlotte Hands Plovdiv,Lee Gethings,Jim Langridge,Karine Adel-Patient,Hervé Bernard,Ivona Barcievic-Jones,Raditsa Sokolova,Rumyana Yankova,Mariya Ivanovska,Marianna Murdjeva,Tatyana Popova,Svetlan Dermendzhiev,Martin Karjalainen,Ulrike Lehnigk,Duncan Brown,Julie C. Locklear,Julie Locklear,Ioana Maris,Jonathan Hourihane,Cristina Ornelas,Joana Caiado,Manuel Branco Ferreira,Manuel Pereira-Barbosa,Yolanda Puente,Juan Carlos Daza,Francisco Javier Monteseirin,Natalia Ukleja-Sokolowska,Ewa Gawronska-Ukleja,Magdalena Zbikowska-Gotz,Zbigniew Bartuzi,Lukasz Sokolowski,Aine Adams,Bernard Mahon,Karen English,Nelly Gourdon-Dubois,Laetitia Sellam,Bruno Pereira,Elodie Michaud,Khaled Messaoudi,Bertrand Evrard,Jean-Luc Fauquert,Francisca Palomares,Gador Gomez,Maria Jose Rodriguez,Luisa Galindo,Ana Molina,Lorella Paparo,Maurizio Mennini,Rosita Aitoro,Adam Wawrzeńczyk,Michał Przybyszewski,Anna Wawrzeńczyk,Hulya Ercan Sarıcoban,Meltem Ugras,Zerrin Yalvac,Bertine M. J. Flokstra-de Blok,J. L. van der Velde,Andrea Vereda,Clara Ippolito,Amaranta Traversa,Daniela Adriano,Daniela Manila Bianchi,Silvia Gallina,Lucia Decastelli,Melina Makatsori,Anne Miles,Sonja Posega Devetak,Iztok Devetak,Soraya Ainad Tabet,Jeanette Fisker Trandbohus,Pernille Winther,Hans-Jørgen Malling,Kirsten Skamstrup Hansen,Lene Heise Garvey,Chia-Chi Wang,Yin-Hua Cheng,Chun-Wei Tung,Mariola Dietrich,Ingo Marenholz,Birgit Kalb,Sarah Grosche,Katharina Blümchen,Rupert Schlags,Mareike Price,Sylke Rietz,Jorge Esparza-Gordillo,Susanne Lau,Young-Ae Lee,Ali Almontasheri,Mohammad Al Bahkali,Sahar Elshorbagi,Abdullah Alfhaid,Mashary Altamimi,Eman Madbouly,Hassan Al-Dhekri,Rand K. Arnaout,Maria Basagaña,Sira Miquel,Borja Bartolomé,Bettina Brix,Stefanie Rohwer,Sandra Brandhoff,Alena Berger,Waltraud Suer,Alf Weimann,Cristina Bueno,Laura Martín-Pedraza,Sara Abián,Pablo San Segundo-Acosta,Juan Carlos López-Rodríguez,Rodrigo Barderas,Eva Batanero,Javier Cuesta-Herranz,María Teresa Villalba,Magna Correia,Filipe Benito-Garcia,Cristina Arêde,Susana Piedade,Mário Morais-Almeida,James Hindley,Ross Yarham,Anna Kuklinska-Pijanka,David Gillick,Karine Patient,Martin D. Chapman,Katrine L. Bøgh,Ana Miranda,Eugénia Matos,Anna Sokolova,Huan Rao,Ivona Baricevic-Jones,Frances Smith,Wentong Xue,Helga Magnusdottir,Anna G. Vidarsdottir,Sigrun Lund,Anders Blom Jensen,Bjorn R. Ludviksson,Reyna Simon,Robert Elfont,Sean Bennett,Robert Voyksner,Maria de Lurdes Torre,Songül Yürek,Margaretha A. Faber,Annick Bastiaensen,Evelyne Mangodt,Athina van Gasse,Ine Decuyper,Vito Sabato,Margo M. Hagendorens,Chris H. Bridts,Luc S. De Clerck,Didier Ebo,Susanne Schwarz,Mandy Ziegert,Saskia Albroscheit,Christian Schwager,Skadi Kull,Jochen Behrends,Niels Röckendorf,Frauke Schocker,Andreas Frey,Arne Homann,Wolf-Meinhard Becker,Uta Jappe,Nesrine Zaabat,Sylvia Osscini,Chantal Agabriel,Benoît Sterling,Ania Carsin,Valérie Liabeuf,Monica Maćków,Alina Zbróg,Monica Bronkowska,Justine Courtois,Romy Gadisseur,Catherine Bertholet,Pierre Lukas,Etienne Cavalier,Philippe Delahaut,Birgit Quinting,Margareta Brandt Gertmo,Ewa Ternesten Hasseus,Vladyslava Barzylovych,Júlio Oliveira,Luis F. Ensina,Carolina S. Aranda,Leire Dopazo,Rebeca Lopez,Raquel Perez,Laura Santos-Diez,Agurtzane Bilbao,Juan Miguel Garcia,Ignacio García Núñez,María Ángeles Algaba Mármol,María José Barasona Villarejo,José Antonio Bácter Martos,Marina Suárez Vergara,José María Ignacio García,Agata Michalska,Grzegorz Sergiejko,Robert Zacniewski,Ileana-Maria Ghiordanescu,Cristina Deaconu,Mihaela Popescu,Roxana Silvia Bumbacea,Alkerta Ibranji,Elida Nikolla,Gjustina Loloci,Nanna Juel-Berg,Lau Fabricius Larsen,Lars Kjaergaard Poulsen,João Marcelino,Ricardo Prata,Ana Célia Costa,Fátima Duarte,Marta Neto,Jennifer Santos,Luís Câmara Pestana,Daniel Sampaio,Paola Minale,Paola Dignetti,Donatella Bignardi,Irena Nedelea,Florin-Dan Popescu,Mariana Vieru,Florin-Adrian Secureanu,Carmen Saviana Ganea,Miguel Vieira,José Pedro Moreira Silva,Timothy Watts,Sophia Watts,Marta Lomikovska,Marina Peredelskaya,Natalia Nenasheva,Ivana Filipovic,Zorica Zivkovic,Djordje Filipovic,Jennette Higgs,Amena Warner,Carla Jones

DOI: https://doi.org/10.1186/s13601-017-0142-2

2017-01-01

Clinical and Translational Allergy

Abstract:ORAL ABSTRACT SESSION 1: Food allergens • AnaphylaxisOP01 Fatal anaphylaxis is decreasing in France: analysis of national data, 1979–2011Guillaume Pouessel1,2,3, Claire Claverie4, Julien Labreuche5, Jean-Marie Renaudin3,6, Aimée Dorkenoo4, Mireille Eb7, Anne Moneret-Vautrin6, Antoine Deschildre2,3, Stephane Leteurtre4 1Department of Pediatrics, Children's Hospital, Roubaix, France; 2Division of Pulmonology and Allergology, Department of Pediatrics, Faculty of Medicine and Children's Hospital, Lille, France; 3Allergy Vigilance Network, Vandoeuvre les Nancy, France; 4Université Lille 2, CHU Lille, EA 2694 - Santé Publique: épidémiologie et qualité des soins, Lille, France; 5Biostatistic Unit, Maison Régionale de la Recherche Clinique, CHRU Lille, Lille, France; 6Department of Allergology, Emile Durkheim Hospital, Epinal, France; 7Centre d'Epidémiologie sur les Causes Médicales de Décès INSERM, CHU de Bicêtre, Le Kremlin-Bicêtre, France Correspondence: Guillaume Pouessel - guillaume.pouessel@gmail.com Clinical and Translational Allergy 2017, 7(Suppl 1):OP01 Introduction: Incidence of anaphylaxis is increasing. Data regarding anaphylaxis mortality are limited, but conflicting. Our objective was to document anaphylaxis mortality rate (deaths per million population), time trends and specificities according to triggers (iatrogenic, venom, food, unknown), age groups, sex and geographical regions (North and South) in France, between 1979 and 2011. Methods: Data were obtained (1) from database of the National Mortality Center (CEPIDC) to collect cases in which anaphylaxis was included as a cause of death, sex, age, and geographic region of death, (2) from the database of the National Institute for Economical and Statistical studies (INSEE) to define the referent populations. We used a multivariable log-linear Poisson regression model to assess the impact of time period, age, sex and geographic region on anaphylaxis deaths. Results: During the period study, 1603 deaths were collected: 1564 in adults and 39 in children (age <18 year). The overall prevalence of anaphylaxis fatalities was 0.84 per million population (95% IC 0.80–0.88), ranging from 0.08 per million (95% IC 0.05–0.10) in pediatric population to 1.12 per million (95% CI 1.06 to 1.17) in adult population. Annual percentage change for case fatality rate was −2.0% (95% CI −2.5 to −1.5; p < 10−4) indicating a decrease in case fatality rate during the study period. Anaphylaxis fatality rate was higher in men (1.08 per million [95% IC 1.00 1.16] than women (0.86 per million [95% IC 0.80–0.92]) (p < 10−4). Triggers of anaphylaxis fatalities were iatrogenic (63%), mostly drugs, venom (14%) and food (0.6%). Unspecified anaphylaxis was frequent (23%). The highest rate was in persons aged >70 years (3.50 per million population per year [95% IC 3.25–3.76]) and the lowest in the pediatric population (p < 10−4). Only venom-induced mortality rate was higher in South of France (0.16 per million [95% IC 0.13–0.19]) compared with the North (0.11 per million [95% IC 0.09–0.13]) (p = 0.004). Only 8 food-induced fatalities were recorded (age <35 years in 7 cases). Conclusion: Overall anaphylaxis mortality rate is decreasing over the three last decades in France. We confirm that iatrogenic causes are the most frequent causes. Older age and male sex are risk factors of fatal anaphylaxis of any cause except for food-induced anaphylaxis.OP02 Diagnostic workup after severe anaphylaxisLinus Grabenhenrich1, Margitta Worm1, Sabine Dölle1, Kathrin Scherer2, Isidor Hutteger3 1Charité - Universitätsmedizin Berlin, Berlin, Germany; 2University Hospital Basel, Basel, Switzerland; 3Universitätsklinikum Salzburg, Salzburg, Austria Correspondence: Linus Grabenhenrich - linus.grabenhenrich@charite.de Clinical and Translational Allergy 2017, 7(Suppl 1):OP02 Introduction: After a severe anaphylactic reaction, a diagnostic workup is recommended to confirm or rule out the elicitor(s) in question. The type of diagnostic chosen is usually based on the elicitor and severity of the reaction and might follow local experiences. We aimed to describe elicitor-specific diagnostic habits in the workup of severe anaphylaxis, comparing European countries. Methods: The Network for Online Registration of Anaphylaxis (NORA) collected details about elicitors, symptoms and severity, treatment and the diagnostic workup of patients who experienced at least one episode of severe anaphylaxis, as documented within medical records of participating tertiary referral centres. Results: Between June 2011 and April 2016, the registry collected data for 6465 cases of severe anaphylaxis, 74% of which reported to know the elicitor, with a remaining 20% having only a suspicion and 6% cases of idiopathic anaphylaxis. The allergen was known and confirmed by a diagnostic test in 4410 (92% of known elicitors). Of these, 68% had a reaction to this allergen for the first time, and 32% reported at least one earlier reaction to the same allergen. In first-time reactors (n = 3001) 7% reported that the allergen was confirming by a diagnostic test already before this reaction, for food 14%, insects 3%, drugs 2%, and 80% for SIT-induced anaphylaxis. Of cases with recurrent anaphylaxis (n = 1409), 30% had a test confirming the allergen before the reported reaction, for food 44%, insects 16%, drugs 18%, and 91% for SIT-induced anaphylaxis. Of all diagnostically confirmed cases of food-induced anaphylaxis (n = 1555), 78% were assessed by a skin test (SPT, positive in 93%), 90% by specific IgE (sIgE, 94% positive), 27% tryptase (7% positive), and 13% underwent an oral food challenge (positive in 88%). Patients with anaphylaxis caused by drugs had the following tests (positives of these): SPT 88% (49%), sIgE 31% (46%), tryptase 48% (11%), and provocation 19% (68%). For reactions against insect venom: SPT 79% (84%), sIgE 98% (97%), and tryptase 93 (8%). Irrespective of the elicitor, SPTs were performed more often in Austria, Ireland and Greece (92, 96, and 99%, respectively), and less often in Italy (64%). Tryptase was almost never measured in Ireland, Greece and France, whereas determination of specific IgE was carried out similarly between European countries. Conclusion: The choice of diagnostic measure depended on the elicitor and varied by country. Especially the assessment of tryptase is handled very differently between allergens in question and countries. These differences may indicate aspects of the diagnostic workup with a certain degree of ambiguity, which might benefit from further harmonization.OP03 Primary sensitisation versus co-sensitisation to hydrolysed wheat proteinMorten Christensen, Carsten Bindslev-Jensen, Charlotte MortzDepartment of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark Correspondence: Morten J. Christensen - morten.junker.christensen@rsyd.dk Clinical and Translational Allergy 2017, 7(Suppl 1):OP03 Introduction: Wheat protein is responsible for various phenotypes of allergic diseases. More recently an increased number of immediate type 1 allergic reactions to hydrolyzed wheat proteins (HWP) have been reported.The aim of this study was to characterize the clinical profile and evaluate patients with a case-history of anaphylaxis related to ingestion of a product containing HWP. Furthermore, to describe patients with other types of wheat allergy co-sensitized for HWP. Methods: From May 2010 to August 2015 we investigated 56 patients (31 female, 25 male, mean age 39.0 years [1.5–77.2]) sensitized to commercialized HWP, either by specific immunoglobulin E (sIgE) (ThermoFischer, Uppsala, Sweden) and/or skin prick test (SPT). Based upon case-history patients were divided into 3 groups: (1) allergic reaction to ingestion of a HWP containing product (n = 9) (2) ingestion of a wheat product; WIA (n = 19), (3) ingestion of a wheat product in combination with exercise; WDEIA (n = 28). All patients were orally challenged with the incriminated food. Results: The total positive rate of sIgE to HWP was 47/56 (83.9%), SPT 35/42 (83.3%) and BHR 22/42 (52.3%). Fourteen patients were triple positive to commercialized HWP of whom 7/9 patients in the HWP group. In total 9 (16%) patients were identified with a case-history of anaphylaxis related to a HWP containing product. Seven of 9 had a case-history to the same hydrolyzed wheat product (AMO Letbagt®). The average serum level of HWP-sIgE and the SPT were higher in patients with a case-history of HWP, respectively (median 5.3 kU/L ±6.8) (p < 0.05) and (median 6.0 mm ±4.1) (p < 0.05) compared to the WIA and WDEIA groups. A complete negative pattern was determined with specific wheat proteins normally associated with other phenotypes of wheat allergy, omega-5 gliadin (f416), gliadin (f98), High Molecular Weight (Tri a 26) and α-amylase trypsin inhibitor (Tri a 30). Basophil histamine release (BHR) for HWP was extremely positive in 8/9 HWP patients with activity retained to dilutions up to 10−12. The most striking finding was the ultrahigh sensitivity of BHR in diagnosing allergy to HWP. It is, however, interesting, that the HWP patient tolerates ingestion of unmodified wheat. Conclusion: Reactivity to HWP seems to be confined to patients specifically sensitized to this heterogeneous group of products without concomitant allergy to normal wheat. Irrelevant co-sensitization is also seen in classical wheat allergy.OP04 Actual adrenalin treatment in a specialised clinical setting, compared to administration as recommended by a built-in algorithm in a severity scoring instrument in food allergyEsben Eller, Henrik Fomsgaard Kjaer, Charlotte Mortz, Carsten Bindslev-JensenOdense University Hospital, Odense, Denmark Correspondence: Esben Eller - esben.eller@rsyd.dk Clinical and Translational Allergy 2017, 7(Suppl 1):OP04 Introduction: One of the most used severity scoring instruments, the Sampson 1–5, includes a built-in algorithm indicating symptoms which necessitate adrenalin administration. These include grade 5 anaphylactic symptoms, but also grade 3 and 4 such as laryngeal "puritus, tightness, or dysphagia" and lower respiratory symptoms such as "wheezing, dyspnea or cyanosis". Our aim was to compare the recommended adrenalin administration with the actual administration in our clinic in relation to the underlying eliciting symptom. Methods: Data from 2382 positive food challenges (mean age 11.6 years [range: 0.5–74.1y]) performed between Jan. 2000 and Dec. 2015 at the Allergy Centre, Odense, Denmark were included, and severity of reactions was assessed using the Sampson 1–5 severity instrument. All patients were evaluated by experienced specialists during challenge. Actual medications administered during the challenges, i.e. adrenalin, β2-agonist, corticosteroid, or antihistamine were compared with recommended adrenalin treatment according to the algorithm in Sampson 1–5. Results: Out of 346 challenges scored as grade 4 anaphylaxis, 296 were terminated due to respiratory symptoms requiring adrenalin according to Sampson 1–5, i.e. "barky cough, hoarseness, difficulty swallowing" (laryngeal, n = 79), "wheezing, dyspnea, cyanosis" (lower resp. n = 181) or both (n = 36). Nine of the 115 patients with laryngeal symptoms were treated with adrenalin, all due to inspiratory stridor. No patients with lower respiratory symptoms received adrenalin, but the majority were treated with β2 agonists (188/217), whereas in 30 challenges, symptoms disappeared without treatment or only antihistamine for concomitant urticaria were used. Patients solely with laryngeal symptoms received β2-agonists in 16 challenges, but the majority of them (54/79) received no treatment or only antihistamine. The 36 patients with both laryngeal and lower respiratory symptoms were treated in same manner as patients with only lower respiratory symptoms, i.e. β2 agonist for their bronchial wheeze or asthma. Grade 5 anaphylaxis was seen in 11 challenges, 1 caused by non-adrenalin recommended "loss of bowel control". In the remaining 10 cases, 7 patients were treated with adrenalin, either due to "hypotension < 90 mm Hg" (n = 3) or "unconsciousness" (n = 4). Three children fainted, but regained consciousness without administration of adrenalin. Grade 5 anaphylaxis should almost always be treated with adrenalin, whereas adrenalin only was administrated to inspiratory stridor and not to bronchial expiratory wheeze or asthma in grade 4 anaphylaxis. Respiratory signs were instead medicated according to symptoms, i.e. with β2-agonist to relieve bronchoconstriction. All patients were evaluated by experienced specialists, and therefore this practice should be addressed with care in less experienced settings. Conclusion: Inspiratory stridor was the main cause of adrenalin treatment in grade 4 anaphylaxis, whereas the majority of lower respiratory symptoms were treated with inhalant β2 agonists, thereby overcoming the need for adrenalin. This needs to be considered in future treatment recommendations.OP05 Do patients know how to use adrenaline auto-injectors?Leonor Carneiro-Leão†, Jenny Badas†, Luís Amaral, Alice CoimbraServiço de Imunoalergologia, Centro Hospitalar de São João, Porto, Portugal †The first two authors have equal contribution. Correspondence: Leonor Carneiro-Leão - leonorcarneiroleao@gmail.com Clinical and Translational Allergy 2017, 7(Suppl 1):OP05 Introduction: Adrenaline auto-injectors (AAI) are the first line treatment for anaphylaxis in community settings. Two are currently available in Portugal (Anapen® and Epipen®).Our aim was to evaluate patient's ability to properly use AAIs; impact of device switching and patients' preferences. Methods: Patients who had been prescribed an AAI in our department were invited to demonstrate correct technique of AAI by simulating adrenaline administration using training devices. First, simulation with their prescribed AAI; second, evaluation of device switching, without any previous training, by simulating injection with a different AAI (Epipen® or Anapen®, as well as Emerade®-currently unavailable in Portugal). Finally, they were asked which device they liked the best. Results: Thirty-two patients were enrolled, 16 (50%) females, with a mean (SD) age of 42.9 (±15.8) years; 18 (56%) with hymenoptera venom allergy and 14 (44%) food allergy. Anapen® was prescribed to 15 (47%) and Epipen® to 17 (53%). Six did not acquire any AAI; 21 (66%) admitted carrying it on a daily basis. Eleven (34%) could not demonstrate successful adrenaline administration with their prescribed AAI, 5 with Anapen® and 6 with Epipen®. Nine (60%) of the 15 patients who were prescribed an Anapen® could not administer adrenaline with an Epipen®; 11 (65%) of the 17 with a prescribed Epipen® were unable to use an Anapen®. Only 2 (6%) were incapable of properly managing an Emerade®. The most common error in patients switching from Epipen® to Anapen® was not removing the needle cap (9 patients). In the group switching Anapen® to Epipen®, the most common misuse was not massaging the injection site (10 patients); 6 tried to remove the orange tip as if it was a cap. The preferred AAI was Emerade® in 20 (63%) and Epipen® in 12 (37%). Conclusions: Patients at-risk for anaphylaxis are provided with portable auto-injectors, educated and trained on their use. One-third of the patients did not always carry them. More than one-third was unable to successfully demonstrate adrenaline administration with their prescribed AAI. Almost two-thirds failed to simulate injection when switched to the alternative one available in Portugal without any training. Design appears to play a role in a successful switch since 94% of the patients changing from either Anapen® or Epipen® to Emerade® were able to correctly use it. It was also the overall preferred auto-injector. These emergency medical devices should be patient friendly.OP06 Incidence, clinical features, triggers and management of anaphylaxis in the Pediatric Emergency Department of the Tel Aviv Medical CenterDikla Pivko Levy1, Moshe Ben-Shoshan2, Ayelet Rimon1, Shira Benor1 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 2Montreal Children's Hospital, Montreal QC, Canada Correspondence: Dikla Pivko Levy - diklapivko@gmail.com Clinical and Translational Allergy 2017, 7(Suppl 1):OP06 Introduction: Anaphylaxis is a severe, life threatening systemic hypersensitivity reaction. The diagnosis of anaphylaxis is not always easy to make in the pediatric emergency department (ED) setting. Therefore, children are often dangerously underdiagnosed and undertreated. There is sparse information on the incidence and triggers of anaphylaxis in Israel.Our objective was to assess the true incidence of anaphylaxis treated in the Pediatric ED, to identify triggers associated with anaphylaxis, to describe the management of anaphylactic reactions and identify potential gaps in diagnosis and treatment. Methods: A retrospective chart review of cases presenting to the Pediatric ED of the Dana-Dweck Children's hospital, at the Tel Aviv Sourasky Medical Center between January 1st 2013 to December 31th 2014, with a diagnosis of anaphylaxis or allergic reaction. The clinical features, causative agents, treatment administered and recommendations at discharge were recorded. Results: During the study period, there were a total of 56,596 visits to the ED. 437 patients were diagnosed with an allergic or anaphylactic reaction. Of these 59 (13.5%) met the diagnostic criteria for anaphylaxis, but only 22 were given the correct diagnosis. The mean age of presentation was 6.9 years, with a male predominance of 66%. Food was the most common causative agent (78%). Specifically, exposure to treenuts (28% (and cow milk (24%) were responsible for a majority of the cases. The majority of children (78% (had known food allergies and presented with breathing difficulties (64%), followed by urticaria (62%). Twenty children (37.7%) were treated with IM adrenaline prior to ED arrival and only fifteen (26%) were treated with IM adrenaline in the ED. Most of the children (86%) were discharged home. Almost 30% were discharged without a prescription to an automated Adrenaline injector. Conclusion: The rate of anaphylaxis in the study period was 0.1% of all visits to the pediatric ED. Most cases of anaphylaxis were underdiagnosed. As a result, treatment guidelines regarding the use of IM Adrenalin were not always followed and many children were discharged without a prescription for an adrenaline auto-injector.